share_log

Rodman & Renshaw Initiates Coverage On FibroBiologics With Buy Rating, Announces Price Target of $12

Rodman & Renshaw Initiates Coverage On FibroBiologics With Buy Rating, Announces Price Target of $12

Rodman & Renshaw对FibroBiologics启动覆盖,给予买入评级,宣布目标价为12美元。
Benzinga ·  12/12 18:03  · 评级/大行评级

Rodman & Renshaw analyst Elemer Piros initiates coverage on FibroBiologics (NASDAQ:FBLG) with a Buy rating and announces Price Target of $12.

Rodman & Renshaw 分析师Elemer Piros 发起对FibroBiologics (纳斯达克:FBLG) 的覆盖,给予买入评级,并宣布目标价为12美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发